JPMorgan analyst Andrea Teixeira lowered the firm’s price target on Keurig Dr Pepper to $36 from $39 and keeps an Overweight rating on the shares ahead of the Q2 report. The shares offer an attractive valuation ahead of a potential coffee recovery, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on KDP:
- Keurig Dr Pepper price target lowered to $37 from $40 at Wedbush
- Buy/Sell: Wall Street’s top 10 stock calls this week
- AmEx downgraded, Keurig Dr Pepper upgraded: Wall Street’s top analyst calls
- Early notable gainers among liquid option names on July 6th
- Keurig Dr Pepper upgraded to Overweight from Equal Weight at Morgan Stanley